Association of Toll-Like Receptor 7 (TLR7) Polymorphisms with Predisposition to Systemic Lupus Erythematosus (SLE): A Meta and Trial Sequential Analysis

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2023 Dec 16

PMID 38103124

Authors

Shovit Ranjan

Aditya K Panda

Affiliations

Soon will be listed here.

Abstract

Systemic Lupus Erythematosus (SLE) is an autoimmune disorder characterized by autoantibody production and organ involvement. The role of toll-like receptor-7 in SLE is well established. Although genetic variations in the TLR-7 gene have been associated with an increased risk of developing SLE, the findings are not consistent. We performed a meta-analysis of previously published articles on four important single nucleotide polymorphisms in the TLR-7 gene (rs3853839, rs179008, rs179019, and rs179010) to reach a valid conclusion. Various literature databases, including PubMed, Science Direct, and Scopus, were scoured for eligible reports until May 10, 2023. GPower software v.3 was used to assess the power of individual reports included in the meta-analysis. Comprehensive Meta-analysis v3 software was used to perform all statistics. The publication biases in each genetic comparison model were investigated using funnel plots and Egger's regression test. To test heterogeneity, Cochrane Q statistics, probability value and I were used. Considering the predefined inclusion and exclusion criteria, the current study included a total of 10 eligible studies that included 15,472 SLE cases and 16,721 healthy controls. The meta-analysis revealed a significant association between TLR7 polymorphisms (rs179019 and rs179010) and susceptibility to SLE development. Other TLR7 polymorphisms (rs3853839 and rs179008), on the other hand, showed no significant association. Furthermore, the trial sequential analysis identified the need for additional case control studies for TLR-7 polymorphisms (rs3853839, rs179008, and rs179019) other than the rs179010 polymorphism. TLR7 variants for rs179010 and rs179019 are risk factor for the development of SLE. Further investigations are required to reach a valid conclusion.

Citing Articles

Extrafollicular CD19CXCR5CD11c double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus.

Chizzolini C, Guery J, Noulet F, Gruaz L, Cenac C, Frasca L J Transl Autoimmun. 2024; 9:100252.

PMID: 39444662 PMC: 11497371. DOI: 10.1016/j.jtauto.2024.100252.

References

Azab M, Mostafa F, Khalil M, Salama M, Abdelrahman A, Ali A . Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus. Heliyon. 2022; 8(11):e11680. PMC: 9694103. DOI: 10.1016/j.heliyon.2022.e11680. View

Barber M, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow N . Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021; 17(9):515-532. PMC: 8982275. DOI: 10.1038/s41584-021-00668-1. View

Bolouri N, Akhtari M, Farhadi E, Mansouri R, Faezi S, Jamshidi A . Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus. Inflamm Res. 2022; 71(5-6):537-554. DOI: 10.1007/s00011-022-01554-6. View

Celhar T, Magalhaes R, Fairhurst A . TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res. 2012; 53(1-3):58-77. DOI: 10.1007/s12026-012-8270-1. View

Christensen S, Shupe J, Nickerson K, Kashgarian M, Flavell R, Shlomchik M . Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006; 25(3):417-28. DOI: 10.1016/j.immuni.2006.07.013. View

Dalpke A, Helm M . RNA mediated Toll-like receptor stimulation in health and disease. RNA Biol. 2012; 9(6):828-42. PMC: 3495747. DOI: 10.4161/rna.20206. View

Deane J, Pisitkun P, Barrett R, Feigenbaum L, Town T, Ward J . Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007; 27(5):801-10. PMC: 2706502. DOI: 10.1016/j.immuni.2007.09.009. View

Deng Y, Zhao J, Sakurai D, Kaufman K, Edberg J, Kimberly R . MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet. 2013; 9(2):e1003336. PMC: 3585142. DOI: 10.1371/journal.pgen.1003336. View

Diebold S, Kaisho T, Hemmi H, Akira S, Reis e Sousa C . Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004; 303(5663):1529-31. DOI: 10.1126/science.1093616. View

10.

Dos Santos B, Valverde J, Rohr P, Monticielo O, Brenol J, Xavier R . TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus. 2011; 21(3):302-9. DOI: 10.1177/0961203311425522. View

11.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

12.

Elloumi N, Fakhfakh R, Abida O, Hachicha H, Marzouk S, Fourati M . RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features. Int J Immunogenet. 2021; 48(3):250-259. DOI: 10.1111/iji.12531. View

13.

Enevold C, Nielsen C, Jacobsen R, Hermansen M, Molbo D, Avlund K . Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus. Mol Biol Rep. 2014; 41(9):5755-63. DOI: 10.1007/s11033-014-3447-4. View

14.

Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41(4):1149-60. DOI: 10.3758/BRM.41.4.1149. View

15.

Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View

16.

Lee Y . Meta-analysis of genetic association studies. Ann Lab Med. 2015; 35(3):283-7. PMC: 4390695. DOI: 10.3343/alm.2015.35.3.283. View

17.

Lee Y, Lee H, Choi S, Ji J, Song G . Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheumatol. 2012; 30(2):262-5. View

18.

Lee Y, Choi S, Ji J, Song G . Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus. 2016; 25(6):593-601. DOI: 10.1177/0961203315622823. View

19.

Lund J, Alexopoulou L, Sato A, Karow M, Adams N, Gale N . Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004; 101(15):5598-603. PMC: 397437. DOI: 10.1073/pnas.0400937101. View

20.

Lyn-Cook B, Xie C, Oates J, Treadwell E, Word B, Hammons G . Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol. 2014; 61(1):38-43. DOI: 10.1016/j.molimm.2014.05.001. View